Clinical expression of neurotoxic injury and diagnostic use of electromyography.
The clinical features of neurological damage produced by acrylamide, lead, organophosphates, hexacarbon solvents, and methylmercury are described, and the differences in effects of these compounds are stressed. The characteristic pattern of electrophysiological changes for each group of substances are described and correlated with pathological findings.
D000178:Acrylamides / Q000633:toxicity; D000475:Alkenes / Q000633:toxicity; D000818:Animals; D004576:Electromyography; D006586:Hexanes / Q000633:toxicity; D006801:Humans; D007855:Lead Poisoning / Q000503:physiopathology; D008767:Methylmercury Compounds / Q000633:toxicity; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D009943:Organophosphorus Compounds / Q000633:toxicity; D012997:Solvents / Q000633:toxicity
D000178:Acrylamides; D000475:Alkenes; D006586:Hexanes; D008767:Methylmercury Compounds; D009943:Organophosphorus Compounds; D012997:Solvents